Massimo Calafiore
Known title: President & CEOCIK: 0001828602
Massimo Calafiore's purchase track record
Massimo Calafiore has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/9/2025 | OFIX | $125K | +3.3% | +23.5% | +18.9% |
| 3/5/2025 | OFIX | $173K | -37.0% | -14.7% | +10.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OFIX | ▼ Sell | Open Market | 6,031 | $76K | 3/5/2026 | View on chart |
| OFIX | ▼ Sell | Open Market | 6,189 | $80K | 3/4/2026 | View on chart |
| OFIX | ▲ Buy | Grant | 115,119 | $0 | 3/3/2026 | View on chart |
| OFIX | ▼ Sell | Open Market | 9,797 | $149K | 1/12/2026 | View on chart |
| OFIX | ▼ Sell | Open Market | 9,600 | $152K | 1/9/2026 | View on chart |
| OFIX | ▲ Buy | Open Market | 10,000 | $125K | 5/9/2025 | View on chart |
| OFIX | ▲ Buy | Open Market | 9,914 | $173K | 3/5/2025 | View on chart |
| OFIX | ▲ Buy | Grant | 88,339 | $0 | 3/3/2025 | View on chart |
| OFIX | ▼ Sell | Open Market | 9,203 | $158K | 1/13/2025 | View on chart |
| OFIX | ▼ Sell | Open Market | 10,078 | $170K | 1/10/2025 | View on chart |
| OFIX | ▲ Buy | Grant | 141,084 | $1.9M | 1/8/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Orthofix pays $24M in damages to former executives
Orthofix Medical has paid $24 million in damages to former executives. This significant cash outflow may impact the company's financial position. The stock currently trades near its 52-week low, with analysts averaging a $13 target price.
Orthofix pays $24M in damages to former executives. Orthofix Medical has paid $24 million in damages to former executives. This significant cash outflow may impact the company's financial position. The stock currently trades near its 52-week low, with analysts averaging a $13 target price.